(Q43232058)

16 November 2017

title

Severe atopic dermatitis treated with everolimus (English)

1 reference

16 November 2017

1 reference

Sara Gertrudes Anna Van Velsen

series ordinal

1

1 reference

16 November 2017

Inge Marjet Haeck

series ordinal

2

1 reference

16 November 2017

Catharina Ansfrieda Francisca Maria Bruijnzeel-Koomen

series ordinal

3

1 reference

16 November 2017

publication date

1 January 2009

1 reference

Journal of Dermatological Treatment

16 November 2017

published in

1 reference

16 November 2017

volume

20

1 reference

16 November 2017

issue

6

1 reference

16 November 2017

page(s)

365-367

1 reference

Skin-homing T cells in cutaneous allergic inflammation

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09546630903085294

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903085294

Clinical pharmacokinetics of everolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903085294

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903085294

Severe psoriasis treated with a new macrolide: everolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903085294

Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903085294

A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903085294

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546630903085294

10.3109/09546630903085294

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference